Live Breaking News & Updates on Mauna Kea Visitor Center

Stay updated with breaking news from Mauna kea visitor center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Mauna Kea Technologies Announces First of Its Kind U.S. FDA 510(k) Clearance for Use of Cellvizio in a New Category of Molecular Imaging-guided Endoscopic, Laparoscopic, Needle-Based Procedures

Completion of a Major Regulatory Milestone for Molecular Imaging and Precision Medicine as Part of Ongoing Collaboration Regulatory News: Mauna Kea Technologies (Euronext: MKEA, 'Mauna Kea') ....

Thomas Grojean , Mauna Kea , Mauna Kea Technologie , Nicolas Bouvier , International Agency For Research On Cancer , French Financial Markets Authority Autorit , World Health Organization , Major Regulatory Milestone , Molecular Imaging , Precision Medicine , Kea Technologies , Mauna Kea , Target Laboratories , Cellvizio Confocal Miniprobes , Molecular Image Guided Procedures , Interim Chief Executive Officer , Century Cures Act , Mauna Kea Technologies , Registration Document , French Financial Markets Authority , World Health , Incidental Pulmonary ,

Mauna Kea Technologies to Present at 32nd Annual Oppenheimer Healthcare Conference on March 17, 2022

Regulatory News: Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced that ....

Thomas Grojean , Mauna Kea Technologie , Sacha Loiseau , French Financial Markets Authority Autorit , Regulatory News , Kea Technologies , Annual Oppenheimer Healthcare , Mauna Kea Technologies , Registration Document , French Financial Markets Authority ,

Mauna Kea Technologies Announces Start of Enrollment in Peripheral Lung Cancer Multi-Center Clinical Trial

Study will advance the validation of Cellvizio as a real-time biopsy guidance tool during robotic-assisted bronchoscopy that may reduce the near-miss rate of peripheral lung cancer Regulatory News: ....

United States , France General , Thomas Grojean , Sandeep Bansal , Mauna Kea Technologie , Nicolas Bouvier , Ethicon Inc , French Financial Markets Authority Autorit , Auris Health Inc , Lung Cancer Initiative , Lung Center , Johnson Medical Devices Companies , Kea Technologies , Monarch Platform , Auris Health , Confocal Laser Endomicroscopy , Robotic Bronchoscopy , Medical Director , Interventional Pulmonology , Penn Highlands Healthcare , Chief Executive Officer , Mauna Kea , Mauna Kea Technologies , Registration Document , French Financial Markets Authority , Johnson Enterprise Innovation ,

Mauna Kea Technologies Announces its 2022 Financial Calendar

Regulatory News: Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA) inventor of Cellvizio, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform ....

Thomas Grojean , French Financial Markets Authority Autorit , Regulatory News , Kea Technologies , Year Financial Results , Quarter Sales , First Half Sales , Half Financial Results , Mauna Kea Technologies , Universal Registration Document , French Financial Markets Authority , Registration Document , Cap Investor Relations ,

Mauna Kea Technologies Reports Fourth Quarter and Full Year 2021 Sales

Global 2021 sales grew +18% year-over-year to €7.7M Regulatory News: Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA) inventor of Cellvizio, the multidisciplinary probe and ....

United States , Thomas Grojean , Mauna Kea Technologie , Nicolas Bouvier , French Financial Markets Authority Autorit , Kea Technologies , Full Year , Fourth Quarter , Chief Executive Officer , Mauna Kea , Geographic Region , Systems Sold , System Placements , First Quarter Sales , Mauna Kea Technologies , Registration Document , French Financial Markets Authority ,